Clinical Study Design & Methodology
We design clinical studies and prepare protocols and study plans so scientific intent, endpoints and documentation remain aligned.
When this is needed
- You need clinical trial / study design before protocols are locked
- New studies need structured planning before heavy investment
- Protocols show gaps between objectives, endpoints and analysis
- Documentation must stay coherent for review pathways owned by the client
- Multi-stakeholder programmes need a single methodological narrative
Methodology
We start from the decision the study must support, then work backward to design and documentation:
- Objectives & constraints — population, interventions, outcomes, practical limits
- Design options — trial/study design trade-offs made explicit for client decision
- Protocols & study plans — drafting and structuring so endpoints and analysis link coherently
- Cross-check — alignment with biostatistics and regulatory writing tracks
- Handoff — client owns ethics, sponsorship and operational execution unless contracted otherwise
Programme stages: How we work.
In scope
- Clinical trial and study design (methodology advisory)
- Protocol and clinical study plan drafting / structuring
- Alignment with biostatistics and regulatory documentation tracks
Example deliverables
- Design option notes and recommendations for clinical programmes
- Protocol and study plan drafts or restructures
- Consistency reviews against analysis and RA needs
Out of scope
- Acting as sponsor by default
- Guaranteeing ethics or regulator outcomes
- CRO-of-record unless defined in a specific contract
Related
Biostatistics · Regulatory support · Biotech & pharma · Research organisations
Ready to discuss a programme?
Tell us about your organisation and the type of support you need. Do not send PHI or confidential regulatory packs through the public form.